Hancock Holding Co. Invests $234,000 in HCP Inc. (HCP)
Hancock Holding Co. acquired a new position in HCP Inc. (NYSE:HCP) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 6,615 shares of the real estate investment trust’s stock, valued at approximately $234,000.
A number of other institutional investors have also modified their holdings of the company. Penserra Capital Management LLC increased its position in shares of HCP by 1.2% in the second quarter. Penserra Capital Management LLC now owns 3,075 shares of the real estate investment trust’s stock worth $109,000 after buying an additional 37 shares during the last quarter. Iowa State Bank acquired a new position in shares of HCP during the second quarter worth about $145,000. Advisory Services Network LLC increased its position in shares of HCP by 29.2% in the second quarter. Advisory Services Network LLC now owns 4,252 shares of the real estate investment trust’s stock worth $150,000 after buying an additional 961 shares during the last quarter. Checchi Capital Advisers LLC increased its position in shares of HCP by 3.9% in the second quarter. Checchi Capital Advisers LLC now owns 5,288 shares of the real estate investment trust’s stock worth $187,000 after buying an additional 200 shares during the last quarter. Finally, Brown Advisory Securities LLC acquired a new position in shares of HCP during the second quarter worth about $201,000. 90.96% of the stock is owned by institutional investors.
HCP Inc. (NYSE:HCP) traded up 1.612% during midday trading on Thursday, hitting $38.765. 900,309 shares of the stock traded hands. The company’s market cap is $18.13 billion. The company’s 50 day moving average is $38.82 and its 200-day moving average is $35.62. HCP Inc. has a one year low of $25.11 and a one year high of $40.43.
HCP (NYSE:HCP) last released its quarterly earnings data on Tuesday, August 9th. The real estate investment trust reported $0.74 EPS for the quarter, topping analysts’ consensus estimates of $0.70 by $0.04. The firm had revenue of $662.20 million for the quarter, compared to the consensus estimate of $631.25 million. HCP had a negative net margin of 2.52% and a negative return on equity of 0.67%. The firm’s revenue was up 9.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.79 earnings per share. On average, equities research analysts forecast that HCP Inc. will post $2.83 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, August 23rd. Shareholders of record on Monday, August 8th were issued a $0.575 dividend. This represents a $2.30 annualized dividend and a dividend yield of 6.03%. The ex-dividend date of this dividend was Thursday, August 4th. HCP’s dividend payout ratio (DPR) is presently -1,533.33%.
HCP has been the topic of a number of recent analyst reports. Morgan Stanley downgraded HCP from an “equal weight” rating to an “underweight” rating and set a $32.00 price target on the stock. in a research report on Wednesday, June 22nd. Raymond James Financial Inc. initiated coverage on HCP in a research report on Tuesday, July 26th. They set an “underperform” rating on the stock. Mizuho reaffirmed a “hold” rating and set a $32.00 price target on shares of HCP in a research report on Tuesday, July 12th. Jefferies Group reaffirmed a “neutral” rating on shares of HCP in a research report on Wednesday, July 6th. Finally, BMO Capital Markets reaffirmed a “sell” rating on shares of HCP in a research report on Monday, June 20th. Seven investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $34.24.
In other HCP news, EVP Jonathan M. Bergschneider sold 7,651 shares of the company’s stock in a transaction dated Tuesday, August 23rd. The shares were sold at an average price of $39.78, for a total value of $304,356.78. Following the sale, the executive vice president now owns 54,095 shares of the company’s stock, valued at $2,151,899.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Darren A. Kowalske sold 2,250 shares of the company’s stock in a transaction dated Wednesday, August 31st. The shares were sold at an average price of $39.20, for a total transaction of $88,200.00. Following the completion of the sale, the insider now directly owns 9,793 shares in the company, valued at approximately $383,885.60. The disclosure for this sale can be found here. 0.22% of the stock is currently owned by company insiders.
HCP Company Profile
HCP, Inc (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital.
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP Inc. (NYSE:HCP).
Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.